A Randomized, Double Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Dupilumab in Patients With Persistent Asthma
Phase of Trial: Phase III
Latest Information Update: 18 Dec 2017
At a glance
- Drugs Dupilumab (Primary)
- Indications Asthma
- Focus Registrational; Therapeutic Use
- Acronyms Liberty Asthma Quest
- Sponsors Sanofi
- 14 Dec 2017 Status changed from active, no longer recruiting to completed.
- 01 Dec 2017 This trial has been completed in Hungary according to European Clinical Trials Database record.
- 27 Sep 2017 This trial has been completed in Spain.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History